Naho Kagiyama

Saitama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Risk Factors for Pneumonitis in Patients with Unresectable Advanced Non-small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.

Risk Factors for Pneumonitis in Patients with Unresectable Advanced Non-small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.

Journal: Internal medicine (Tokyo, Japan)

Published: March 26, 2026

Serum TARC Level as a Predictive Marker of Severe Disease in COVID-19 during the Omicron Variant Period of the Pandemic.

Serum TARC Level as a Predictive Marker of Severe Disease in COVID-19 during the Omicron Variant Period of the Pandemic.

Journal: Internal medicine (Tokyo, Japan)

Published: November 20, 2024

Prognostic Impact of Pulmonary Diseases in 952 Patients with Thoracic and/or Abdominal Aortic Aneurysm.

Prognostic Impact of Pulmonary Diseases in 952 Patients with Thoracic and/or Abdominal Aortic Aneurysm.

Journal: Journal of clinical medicine

Published: September 29, 2024

Analysis of immune checkpoint inhibitors for advanced non-small cell lung cancer in patients receiving antacids.

Analysis of immune checkpoint inhibitors for advanced non-small cell lung cancer in patients receiving antacids.

Journal: Respiratory investigation

Published: June 12, 2024

Antibody titers among healthcare workers for coronavirus disease 2019 at 6 months after BNT162b2 vaccination.

Antibody titers among healthcare workers for coronavirus disease 2019 at 6 months after BNT162b2 vaccination.

Journal: Vaccine

Published: February 15, 2022

Clinical Features of Fibrosing Mediastinitis in Japanese Patients: Two Case Reports and a Literature Review.

Clinical Features of Fibrosing Mediastinitis in Japanese Patients: Two Case Reports and a Literature Review.

Journal: Internal medicine (Tokyo, Japan)

Published: May 24, 2021

Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial.

Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial.

Journal: Infectious diseases and therapy

Published: May 21, 2021

A retrospective analysis of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy for advanced or recurrent non-small cell lung cancer.

A retrospective analysis of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy for advanced or recurrent non-small cell lung cancer.

Journal: Thoracic cancer

Published: January 05, 2021

Outcome and risk factor of immune-related adverse events and pneumonitis in patients with advanced or postoperative recurrent non-small cell lung cancer treated with immune checkpoint inhibitors.

Outcome and risk factor of immune-related adverse events and pneumonitis in patients with advanced or postoperative recurrent non-small cell lung cancer treated with immune checkpoint inhibitors.

Journal: Thoracic cancer

Published: August 12, 2020

Clinical course and findings of 14 patients with COVID-19 compared with 5 patients with conventional human coronavirus pneumonia.

Clinical course and findings of 14 patients with COVID-19 compared with 5 patients with conventional human coronavirus pneumonia.

Journal: Respiratory medicine case reports

Published: March 30, 2020

Viral Pneumonia Requiring Differentiation from Acute and Progressive Diffuse Interstitial Lung Diseases.

Viral Pneumonia Requiring Differentiation from Acute and Progressive Diffuse Interstitial Lung Diseases.

Journal: Internal medicine (Tokyo, Japan)

Published: December 17, 2019

Incidence and etiology of chronic pulmonary infections in patients with idiopathic pulmonary fibrosis.

Incidence and etiology of chronic pulmonary infections in patients with idiopathic pulmonary fibrosis.

Journal: PloS one

Published: November 13, 2019

Showing 1-12 of 41

Last Updated: 09/26/2026